Using Artificial Intelligence to Unlock Hidden Insights in Genomic Research - with Dr. Mark Kiel of Genomenon

<p><span data-preserver-spaces="true">Today's guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares practical approaches to integrating AI with human curation, improving workflow efficiency, and scaling insights for rare disease diagnosis, trial design, and drug development strategy. This episode is sponsored by</span> <a class="editor-rtfLink" href= "https://www.genomenon.com/" target="_blank" rel= "noopener"><span data-preserver-spaces= "true">Genomenon</span></a...